Net Loss Per Common Share (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2021

Dec. 31, 2020

Earnings Per Share [Abstract]

Summary Of Basic and Diluted Income (Loss) Per Ordinary Share

The following table sets forth the computation of basic and diluted net loss per common share attributable to common stockholders (in thousands, except share and per share data):

	Three Months Ended March 31,
	2021			2020
Numerator:
Net loss	$	(20,957	)	$	(18,693	)
Denominator:
Weighted average shares used to compute basic and diluted net loss per share		55,688,281			7,767,169
Net loss per common share—basic and diluted	$	(0.38	)	$	(2.41	)

Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Common Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:

	Three Months Ended March 31,
	2021		2020
Redeemable convertible preferred stock		—		4,384,348
Options to purchase common stock		24,626,748		1,467,347
Unvested RSA		34,932		26,908
Restricted stock units		959,874		—
Unvested early exercised common stock options		3,935,428		89,431
Vested and early exercised options subject to nonrecourse notes		1,761,436		—
Preferred stock warrants		—		37,285
Public and private common stock warrants		15,999,996		—
Total		47,318,414		6,005,319

Schedule of Outstanding Shares of Potentially Dilutive Securities

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:

	Year Ended December 31,
	2019		2020
Redeemable convertible preferred stock		4,384,348		88,434,754
Options to purchase common stock		1,599,645		25,732,503
Unvested RSA		34,865		146,675
Unvested early exercised common stock options		120,984		6,212,254
Vested and early exercised options subject to nonrecourse notes		—		2,151,100
Preferred stock warrants		37,285		4,443,862
Total		6,177,127		127,121,148